tetano
Editor, Senior Moderator
J Pediatric Infect Dis Soc
. 2021 Nov 3;piab098.
doi: 10.1093/jpids/piab098. Online ahead of print.
Return to School and COVID-19 Vaccination for Pediatric Solid Organ Transplant Recipients in the United States: Expert Opinion for 2021-2022
Kevin J Downes[SUP] 1 2 [/SUP], Victoria A Statler[SUP] 3 4 [/SUP], Rachel C Orscheln[SUP] 5 6 [/SUP], Melissa K Cousino[SUP] 7 8 [/SUP], Michael Green[SUP] 9 10 [/SUP], Marian G Michaels[SUP] 9 10 [/SUP], William J Muller[SUP] 11 12 [/SUP], Tanvi S Sharma[SUP] 13 14 [/SUP], Lara A Danziger-Isakov[SUP] 15 16 [/SUP], Monica I Ardura[SUP] 17 18 [/SUP]
Affiliations
Abstract
The COVID-19 pandemic continues to generate challenges for pediatric solid organ transplant (SOT) recipients and their families. As rates of COVID-19 fluctuate, new SARS-CoV-2 variants emerge, and adherence to and implementation of mitigation strategies vary from community to community, questions remain about the best and safest practices to prevent COVID-19 in vulnerable patients. Notably, decisions about returning to school remain difficult. We assembled a team of specialists in pediatric infectious diseases, transplant infectious diseases, public health, transplant psychology, and infection prevention and control to re-address concerns about school re-entry, as well as COVID-19 vaccines, for pediatric SOT recipients in the United States in 2021. Based on available literature and guidance from national organizations, we generated expert statements specific to pediatric SOT recipients focused on school attendance in 2021.
Keywords: COVID-19 vaccines; SARS-CoV-2; coronavirus; masks; pediatric transplant; return to school; vaccination.
. 2021 Nov 3;piab098.
doi: 10.1093/jpids/piab098. Online ahead of print.
Return to School and COVID-19 Vaccination for Pediatric Solid Organ Transplant Recipients in the United States: Expert Opinion for 2021-2022
Kevin J Downes[SUP] 1 2 [/SUP], Victoria A Statler[SUP] 3 4 [/SUP], Rachel C Orscheln[SUP] 5 6 [/SUP], Melissa K Cousino[SUP] 7 8 [/SUP], Michael Green[SUP] 9 10 [/SUP], Marian G Michaels[SUP] 9 10 [/SUP], William J Muller[SUP] 11 12 [/SUP], Tanvi S Sharma[SUP] 13 14 [/SUP], Lara A Danziger-Isakov[SUP] 15 16 [/SUP], Monica I Ardura[SUP] 17 18 [/SUP]
Affiliations
- PMID: 34734268
- DOI: 10.1093/jpids/piab098
Abstract
The COVID-19 pandemic continues to generate challenges for pediatric solid organ transplant (SOT) recipients and their families. As rates of COVID-19 fluctuate, new SARS-CoV-2 variants emerge, and adherence to and implementation of mitigation strategies vary from community to community, questions remain about the best and safest practices to prevent COVID-19 in vulnerable patients. Notably, decisions about returning to school remain difficult. We assembled a team of specialists in pediatric infectious diseases, transplant infectious diseases, public health, transplant psychology, and infection prevention and control to re-address concerns about school re-entry, as well as COVID-19 vaccines, for pediatric SOT recipients in the United States in 2021. Based on available literature and guidance from national organizations, we generated expert statements specific to pediatric SOT recipients focused on school attendance in 2021.
Keywords: COVID-19 vaccines; SARS-CoV-2; coronavirus; masks; pediatric transplant; return to school; vaccination.